Skip to Main Content

Paper Details

A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in <i>BRAF</i>-Driven Pediatric Low-Grade Glioma Cells.
Mol Cancer Ther
13
2020
Author NameAffiliation
Viktoria Marquardtand Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
David Pauckand Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Darren HargraveGreat Ormond Street Hospital for Children
Cornelis M van TilburgHopp Children's Cancer Center Heidelberg (KiTZ)
Cornelis M van TilburgKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Cornelis M van TilburgClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Stefan M PfisterKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Marc Remkeand Clinical Immunology, University Hospital Dusseldorf, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Olaf WittKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
Till MildeHopp Children's Cancer Center Heidelberg (KiTZ)
Till MildeClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Till MildeKiTZ Clinical Trial Unit (ZIPO), Heidelberg University Hospital
  • 1 - 26

Datasets